– Arfelli, V.C.; Chang, Y.C.; Bagnoli, J.W.; Kerb, P.; Ciamponi, F.E.; Paz, L.M.D.S.; Pankivskyi, S.; de Matha Salone, J.; Maucuer, A.; Massirer, K.B.; Enard, W.; Kuster, B.; Greif, P.A.; Archangelo, L.F. (2023). UHMK1 is a novel splicing regulatory kinase. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2023.103041
– Serafim, R.B.; Cardoso, C.; Arfelli, V.C.; Valente, V.; Archangelo, L.F. (2022). PIMREG expression level predicts glioblastoma patient survival and affects temozolomide resistance and DNA damage response. Biochim. Biophys. Acta Mol. Basis Dis. https://doi.org/10.1016/j.bbadis.2022.166382
– Arfelli, V.C. and Archangelo, L.F. (2022). Book chapter. Alternative Splicing of Pre-messenger RNA. Transcriptomics in Health and Disease (2nd Edition). Ed. Springer Nature. https://doi.org/10.1007/978-3-030-87821-4_2
– Campos, L.W., Zenatti, P.P., Pissinato, L.G, Rodrigues, G.O.L, Artico, L.L, Guimarães, T.R, Archangelo, L. F., Martínez, L, Brooks, A.J., Yunes, J.A. (2019). Oncogenic basic amino acid insertions at the extracellular juxtamembrane region of IL7Rα cause receptor hypersensitivity. BLOOD. https://doi.org/10.1182/blood-2018-09-872945
– Barbutti, I., Machado-Neto, J., Arfelli, V., Campos, P., Traina, F., Saad, S.T.O, Archangelo, L.F. (2018). The U2AF homology motif kinase 1 (UHMK1) is upregulated upon hematopoietic cell differentiation. Biochim Biophys Acta. https://doi.org/10.1016/j.bbadis.2018.01.004
– Arfelli, V.C.; Archangelo, L.F. (2018). UHMK1 (U2AF homology motif kinase 1); Atlas Genet Cytogenet Oncol Haematol. https://doi.org/10.4267/2042/68931
– Archangelo, L.F. (2017). PIMREG (PICALM interacting mitotic regulator); Atlas Genet Cytogenet Oncol Haematol. https://doi.org/10.4267/2042/68737
– Barbutti, I., Xavier-Ferrucio, J.M., Machado-Neto, J.A., Ricon, L., Traina, F., Bohlander, S.K., Saad, S.T.O. and Archangelo L.F. (2016). CATS (FAM64A) abnormal expression reduces clonogenicity of hematopoietic cells. Oncotarget. https://doi.org/10.18632/oncotarget.11724
– Archangelo, L.F., Greif, P.A., Maucuer, A., Manceau, V., Koneru, N., Bigarella, C.L., Niemann, F., dos Santos, M.T., Kobarg, J., Bohlander, S.K., Saad S. T. O. (2013). The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS). Biochimica et biophysica acta. https://doi.org/10.1016/j.bbamcr.2013.02.004
– Archangelo, L. F., Greif, P., Holzel, M., Harasim, T., Kremmer, E., Przemeck, G., Eick, D., Deshpande, A., Buske, C, Deangelis, M. H., Saad S. T. O., Bohlander S. K. (2008). The CALM and CALM/AF10 interactor CATS is a marker for proliferation. Molecular Oncology. https://doi.org/10.1016/j.molonc.2008.08.001
– Archangelo, L.F., Glasner, J., Krause, A. and Bohlander, S.K. (2006). The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene. https://doi.org/10.1038/sj.onc.1209438